to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
A startup company with a new way to make nanofibers sees many potential applications in the medical business. Xanofi has the technology to make strides in several industries, including the healthcare business.
A new marine biotech center will be established to help companies commercialize biotech-based products originating on the North Carolina coast. The North Carolina Biotechnology Center has awarded a $2.5 million, four-year grant for the center.
Innovations receiving funding at North Carolina State University include two projects with healthcare applications: work on a new Salmonella vaccine and wound-healing bandages.
At-the-market offerings are used for investing in other industries, but they are just starting to pick up in life science investing. Read more on what the healthcare business should know about ATM offerings.
PPD's new CEO Ray Hill brings global knowledge and experience that will help the CRO succeed in today's healthcare business landscape. Read more on CROs and global entrepreneurship.
Pharma reps at GSK are selling their products in a new way. The emphasis is more on communicating a drug's benefits and risks than trying to sell as much as possible. Read more about this change in approach to sales.
Pharmaceutical companies are trying to adapt their marketing to an increasingly digital world. To get a handle on this environment, one company has appointed a digital advisory board of marketers from other industries.
Cloud computing is becoming more popular with companies, including those in health IT. Here are some tips to keep in mind before signing with a cloud vendor.
Regenerative medicine has come a long way in recent years, leading some venture capitalists to consider investing in it. The roadblock to investing in this field is not a lack of funds, but rather a lack of a clear explanation of regenerative medicine's commercial applications, says one former venture capitalist.
Medical device startups will be way ahead of their competitors if they know what to expect from the FDA approval process. Read more for tips on how to be prepared.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.